Corrigenda

Corrigendum to Arif et al. VDAC1 is a molecular target in glioblastoma, with its depletion leading to reprogrammed metabolism and reversed oncogenic properties. Neuro Oncol (doi:10.1093/neuonc/now297) first published online February 28, 2017.

from Cancer via ola Kala on Inoreader http://ift.tt/2AiuF5L
via IFTTT